willdate

1187 POSTS 0 COMMENTS

US FDA approval for AI-powered left ejection fraction detection device

AI
Anumana has announced US Food and Drug Administration (FDA) 510(k) clearance for ECG-AI LEF, a break...

MedAlliance acquired by Cordis

MedAlliance has been acquired by Cordis for a 2022 investment of US$35 million and a 2023 upfront cl...

US FDA grants conditional IDE approval for F2 cerebral embolic protection system

EnCompass Technologies has announced that the US Food and Drug Administration (FDA) has granted cond...

Boston Scientific gains US FDA clearance for AVVIGO+ multi-modality guidance system

Boston Scientific has announced US Food Administration (FDA) clearance of the AVVIGO+ multi-modality...

Surgeons perform historic second transplant of a genetically modified pig heart into a human

Surgeons at the University of Maryland Medical Center (UMMC, Baltimore, USA) have performed the seco...

Nitrate reduces contrast-induced necropathy during coronary angiography

Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces ca...

Nick West appointed to associate CMO role at Shockwave Medical

Shockwave Medical has announced that Nick West has joined the company in the role of associate c...

David Hildick-Smith

As one of the UK’s leaders in interventional cardiology, David Hildick-Smith (University Hospitals S...

Cardiovascular News – Issue 70 – September 2023: US Edition

In this issue: Societies weigh in on renal denervation as US Food and Drug Administration (FDA)...

Cardiovascular News – Issue 70 – September 2023: OUS Edition

In this issue: Societies weigh in on renal denervation as US Food and Drug Administration (FDA)...

Pivotal study of ShortCut leaflet splitting device completes enrolment

Pi-Cardia has announced the successful completion of its ShortCut pivotal study enrolment. ShortC...

ADVERTORIAL: Hypertension guidelines “change the thinking” on renal denervation

This advertorial is sponsored by Medtronic Hypertension is a leading cause of heart attack, strok...

European survey highlights lack of uniformity in heart team implementation

A survey of cardiac surgeons and interventional cardiologists from 26 European nations has highlight...

Updates to HyperVue intravascular imaging system approved by US FDA

SpectraWAVE has announced US Food and Drug Administration (FDA) 510(k) clearance for product enhance...

Enrolment complete in SAFE-MCS study of Early Bird bleed monitoring system

Saranas has completed enrolment in SAFE-MCS, a multicentre, single arm, open-label clinical trial ev...

Half of patients enrolled in SELUTION DeNovo coronary trial

MedAlliance has announced enrolment of over 1,660 patients in its SELUTION DeNovo coronary randomise...

Large annulus valve launched for transseptal mitral valve replacement system

HighLife SAS has announced the introduction of a new valve size in its clinical trials of a transsep...

Ten-year NOTION trial data provide important insights on long-term TAVI outcomes and valve durability

Ten-year data from the NOTION trial—the longest-running clinical trial to date to compare outcom...

Watchman FLX Pro gains US FDA approval

Boston Scientific has received US Food and Drug Administration (FDA) approval for the latest-gen...

Enrolment begins in LOVE-DEB study of Selution SLR sirolimus-eluting balloon

The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease tr...

First-in-man procedure follows US FDA breakthrough designation for NyokAssist PVAD system

The first-in-man (FIM) use of the NyokAssist (magAssist) percutaneous ventricular assist device ...

ESC 2023: Study assesses impact of using Heartflow FFRCT for diagnosing coronary artery disease

A study assessing the impact of the addition of adding coronary computed tomography angiography ...

Sirolimus-eluting Orsiro stent non-inferior to zotarolimus-eluting device in BIOFLOW-DAPT trial

One-year-data from the BIOFLOW-DAPT trial demonstrated non-inferiority and a good safety profile for...

Stroke expert J Mocco joins Protembis board

Protembis has announced the appointment of J Mocco (Icahn School of Medicine at Mount Sinai, New Yor...

Radiaction Medical secures Series C2 funding and announces board addition

Radiaction Medical has raised US$12.6 million in Series C2 funding led by US private equity fund Inn...

UK MHRA adds capacity for medical device certification

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has designated three new app...

ESC 2023: Prolonged clopidogrel monotherapy after PCI in high-risk ACS patients reduces bleeding and ischaemic events

Extended P2Y12 inhibitor monotherapy beyond 12 months  after percutaneous coronary intervention (PCI...

ESC and EACTS conclude review of left main revascularisation guidelines recommendations

A joint review of evidence into the treatment of patients at low surgical-risk with left main corona...

ESC 2023: ECLS not shown to improve survival in patients with acute MI complicated by cardiogenic shock

Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocar...

ESC 2023: ADVENT trial shows PFA is non-inferior to thermal ablation for safety and efficacy in paroxysmal AF

Results of the first randomised trial comparing pulsed field ablation (PFA) to thermal ablation ...

ESC 2023: GE Healthcare showcases latest-generation handheld ultrasound scanner and AF tool

GE Healthcare has announced the launch of two new tools for the cardiology market, coinciding wi...

ESC 2023: Hot Line trials add weight to case for intravascular imaging during PCI

Data from three randomised trials and a meta-analysis presented at the European Society of Cardi...

ESC 2023: Siemens unveils Acuson Origin imaging platform

Siemens Healthineers has unveiled the Acuson Origin, a dedicated cardiovascular ultrasound system wi...

SCAI: FDA panel vote “encouraging” for advance of renal denervation

FDA
The Society for Cardiovascular Angiography & Interventions (SCAI) has welcomed the review of sci...

FDA panel split on risk and benefit of Symplicity Spyral renal denervation system

The US Food and Drug Administration (FDA) Circulatory Systems Devices Panel met yesterday (23 Au...

First two US patients receive Trisol tricuspid valve

The heart teams at the Piedmont Heart Institute (Atlanta, USA) and the University of Virginia He...

FDA panel votes favourably on safety and efficacy of Paradise renal denervation system

The US Food and Drug Administration (FDA) Circulatory Systems Devices Panel of the Medical Devices A...

ESC 2023: Risk of MI recurrence higher in patients who do not take daily aspirin

Myocardial infarction (MI) patients who do not take daily aspirin have an elevated likelihood of rec...

Elevate pLVAD completes early feasibility study

Enrolment has been completed in the US Food and Drug Administration (FDA)-approved early feasibility...

Advanced NanoTherapies secures investment for development of SirPlux Duo DCB

Advanced NanoTherapies—ANT—has announced the completion of a US$4million Series A extension from...

SCAI position statement “aims to pave the way for renal denervation in the management of hypertension”

The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statem...

Bryan Williams joins BHF as research leader

The British Heart Foundation (BHF) has appointed research leader and NHS consultant physician Br...

Sham-controlled trials prompt renal denervation hypertension guideline update

Latest research in the field of renal denervation has prompted its inclusion in updated guidelin...

Forxiga granted approval from China’s NMPA for treatment of symptomatic chronic heart failure

AstraZeneca’s Forxiga (dapagliflozin) has been approved in China for use in adults with symptomatic ...

First patient enrolled in global study of heart failure device trial

Heart failure start-up Acorai has announced the initiation of a global clinical trial with the e...

AI model may improve detection of atrial septal defect

An artificial intelligence (AI) model may be more efficient at detecting signatures of atrial septal...

Efforts needed to improve cardiovascular research in Africa

Research published in the journal Circulation: Cardiovascular Quality and Outcomes has highlight...

STS risk calculator uses power of big data to predict cardiac surgery risk

A new digital tool launched by the Society of Thoracic Surgeons (STS) draws together data from m...

US FDA grants de novo approval for AI-based HCM detection algorithm

Viz.ai has received a de novo approval by the US Food and Drug Administration (FDA) for its Viz ...

STAR-T trial of DrugSorb-ATR completed

CytoSorbents has announced the completion of the pivotal STAR-T (Safe and Timely Antithrombotic Remo...

Orchestra BioMed gains FDA nod to begin study of Virtue SAB sirolimus balloon

Orchestra BioMed Holdings has been granted US Food and Drug Administration (FDA) investigational dev...

First US implants mark start of DurAVR THV early feasibility study

Anteris Technologies has reported that its DurAVR biomimetic, single-piece transcatheter aortic ...

Ilika and Cirtec Medical partner on manufacture and commercialisation of Stereax solid-state batteries

Ilika and Cirtec Medical have announced that they have signed a 10-year manufacturing licence to pro...

VenusP-Valve gains FDA authorisation for transpacific clinical study

VenusP-Valve
Venus Medtech has announced US Food and Drug Administration (FDA) Investigational Device Exemption (...

Canon Medical launches Alphenix / Evolve Edition angiography system in Europe

Canon Medical has introduced its Alphenix / Evolve Edition angiography system for commercial sale in...

“Not just inventing the next stent”: The future of medtech relies on patient empowerment

Ian Meredith is a well-known figure within the field of interventional cardiology, not only for ...

Cardiovascular News’ top 10 stories of July 2023

cardiovascular news top 10
Hitting the headlines in July were new European guidelines on the treatment of arterial hyperten...

CMS creates new MS-DRG codes and payments for coronary IVL

Shockwave Medical has announced that as part of the Fiscal Year 2024 Medicare Hospital Inpatient Pro...

WHO adds cardiovascular polypill to essential medicines list

The World Health Organization (WHO) has included a cardiovascular polypill—an all-in-one pill contai...

TaurusTrio TAVI device gets first implants in aortic regurgitation clinical study

Peijia Medical has announced that the first Chinese patient has been enrolled in the clinical trial ...

Laplace Interventional secures funding for clinical testing of transcatheter tricuspid valve technology

Laplace Interventional, a medical device company developing a transcatheter tricuspid valve tech...

First patients treated in Indian clinical trial of Tria surgical mitral valve

Tria
Foldax has announced that the first 30 patients have been treated outside of the USA in the Indi...

Transfemoral TAVI device gains US FDA breakthrough status for aortic regurgitation

Genesis MedTech has announced that its J-Valve transfemoral (TF) system has been granted breakthroug...

Study confirms AI detection of HFpEF using a single echocardiogram view

Applying artificial intelligence (AI) to a single apical four chamber (A4C) view echocardiogram ...

Results from studies of HeartFlow coronary technologies shared at SCCT conference

Respective results from the REVEALPLAQUE, DECODE, and SMART-CT were presented at the Society of ...

First valve-in-valve procedure performed with DurAVR transcatheter valve

Anteris Technologies has announced that the DurAVR transcatheter heart valve (THV) was used for ...

CardioPrecision moves into US market

CardioPrecision, a developer of less invasive treatment solutions for structural heart disease, has ...

EACTS puts innovation to the fore

Innovation is a part of the DNA of cardiothoracic surgery, Friedhelm Beyersdorf (Heart Center Fr...

Michael Jaff joins board of directors at HeartBeam

HeartBeam, developer of a 3D-vector electrocardiogram (VECG) platform, has announced the appoint...

Clinical trial to compare PCI and CABG in women and minorities

Researchers will carry out the first clinical trial focusing on women and minority populations to de...

Extreme temperatures and particulate pollution may increase MI mortality risk

Extreme temperature
The combination of soaring heat and fine particulate pollution may double the risk of myocardial inf...

Global Cardiovascular Awards to recognise excellence and innovation in cardiovascular care

Entries are now open for the inaugural edition of the Global Cardiovascular Awards, a recognition sc...

Onecrea Medical announces successful first-in-human implants of Crea aortic valve

Onecrea Medical has announced the success of the first-in-human implants of its transcatheter aortic...

PECA Labs appoints new board members

PECA Labs has added Jeffrey P Carpenter, Jeffrey O’Donnell Sr and Samuel E Navarro to its board of d...

SCAI welcomes FDA decision to remove red flag for use of paclitaxel-coated devices in PAD

The president of the Society for Cardiovascular Angiography & Interventions (SCAI), George D...

Ian Meredith joins board of directors at Avertix Medical

Avertix Medical—formerly known as Angel Medical Systems—has announced that Ian Meredith has agre...

TIMELY study will assess impact of AI platform on health of MI patients with coronary disease undergoing cardiac rehabilitation

The TIMELY consortium announced today the enrolment of the first patient in the randomised controlle...

ESH guidelines represent a “significant milestone” for hypertension management

ReCor Medical and its parent company Otsuka Medical Devices have welcomed the release of updated...

INFINITY-SWEDEHEART trial of DynamX bioadaptor system completes enrolment

Elixir Medical has announced enrolment completion in INFINITY-SWEDEHEART, a prospective, multice...

Randomised trial “highly needed” to shed light on effectiveness of TAVI in bicuspid aortic stenosis patients

A dedicated, prospective randomised controlled trial (RCT) investigating the safety, efficacy and li...

Patient advocacy group says ESH guideline change will improve access to renal denervation

Citizens of Europe at risk for heart attacks, stroke and chronic kidney disease due to uncontrolled ...

HOST-IDEA sub-analysis uncovers differences in ultrathin stent platforms

Results of a stent-level analysis from the HOST-IDEA study, which compared two ultrathin strut d...

Gut bacteria linked to coronary atherosclerotic plaques

In a major Swedish study, researchers have discovered a link between the levels of certain bacte...

Timeline: Key milestones in the paclitaxel story

The release of a letter from the US Food and Drug Administration (FDA) concerning the use of paclita...

Approval granted to commence study of renal pelvis denervation system

Verve Medical has received approval from the US Food and Drug Administration (FDA) to initiate its N...

First US patients implanted with FIRE1 remote heart failure monitoring system

FIRE1 has announced that the first US patients have been successfully implanted with its FIRE1 syste...

Long-awaited US FDA update finds data do not support excess mortality risk for paclitaxel-coated devices

In a letter to healthcare providers dated 11 July 2023, the US Food and Drug Administration (FDA...

First patient enrolled in MOJAVE study of DSR 2.0

Sequana Medical NV has announced that the first patient has been enrolled in the MOJAVE study, a ran...

Alvimedica launches Kaplan curves radial portfolio for diagnostic procedures

Alvimedica has announced the launch of the Alvision Kaplan curves radial portfolio for diagnostic pr...

Streamlined TAVI pathway paves the way for same-day discharge “record”

Physicians at the James Cook University Hospital (Middlesbrough, UK) have performed ten transcat...

Researchers develop flexible bioresorbable monitor for cardiac patients

Researchers have developed a soft, fully bioresorbable, transparent microelectrode array (MEA) for m...

“World’s first” dual chamber leadless pacemaker system granted US FDA approval

Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir dual cham...

Key messages from EBC MAIN at three years

EBC MAIN investigator David Hildick-Smith (Brighton, UK) delivers key messages from the trial’s ...

Medtronic heralds ESH guidelines as a “turning point” for renal denervation

In the wake of the release of update guidelines from the European Hypertension Society (ESH) guideli...

Combination of chronic kidney disease and diabetes associated with a higher rate of death or MI among women undergoing PCI

SonieVie
The combined presence of chronic kidney disease and diabetes among women undergoing percutaneous cor...

Minimum level of oxygen required during cardiopulmonary bypass “may be lower than previously thought”

Researchers have found that the minimum level of oxygen delivery during cardiopulmonary bypass may b...

Translumina acquires Blue Medical Devices

Translumina has announced the acquisition of Blue Medical Devices, a Wellinq group company, base...

ALL-RISE study of CathWorks FFRangio system enrols first patient

CathWorks has announced that the first patient has been enrolled in the Advancing cath lab resul...

Depressed ICD patients “more likely to stop medications”

heart attack
Patients who feel low when having a cardiac device implanted are more likely to stop taking thei...

New arterial hypertension guidelines update recommendations on the use of renal denervation

New and expanded guidelines from the European Society of Hypertension (ESH) concerning the managemen...

ECG-AI algorithm for early identification of amyloidosis gains US FDA breakthrough designation

AI
Anumana has received breakthrough device designation from the US Food and Drug Administration (FDA) ...

Vygon to manufacture vascular outflow tract for Aeson artificial heart

Vygon, a specialist in the design, manufacturing and marketing of medical devices, has signed an exc...

iTFlow blood flow analysis software gains US FDA approval

The US Food and Drug Administration (FDA) has approved the use of iTFlow in blood flow analysis. ...

CorWave closes series C funding round

CorWave has raised €61 million to fund its first industrial deployment and entry into clinical trial...

egnite and JenaValve partner to assess prevalence of aortic regurgitation in USA

egnite and JenaValve Technology have announced a strategic partnership aimed to offer insight on the...

Anxiety affects high proportion of patients with an ICD

heart attack
Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in th...

CHOP physicians conduct first-in-human implant of MASA polymeric pulmonary valve

PECA Labs has announced the successful first-in-human implant of the MASA valve, a polymeric valved ...

Pacing wire for TAVI and balloon aortic valvuloplasty procedures gains US FDA clearance

Teleflex has received US Food and Drug Administration (FDA) clearance for the Wattson temporary paci...

STEMI patients “lose years of life” due to care delays during COVID-19 lockdowns

Patients with ST-elevation myocardial infarction (STEMI) occurring during the first COVID-19 loc...

EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis

Results of the first study of a first-generation drug-coated balloon (DCB) with a biolimus coati...

US FDA approval for AI TAVI planning software

AI
Dasi Simulations has announced it has received US Food and Drug Administration (FDA) clearance for i...

ESC appoints Jean-François Riffaud as CEO

The European Society of Cardiology (ESC) has announced the appointment of Jean-François Riffaud ...

Translumina extends European reach with Lamed acquisition

Translumina has announced the acquisition of Munich-based Lamed GmbH, which the company says mov...

US FDA seeks to “modernise” clinical trials with new draft guidance

FDA
The US Food and Drug Administration (FDA) has released draft guidance with updated recommendatio...

Research highlights “strikingly low” use of public defibrillators in cardiac arrest

Defibrillators are being used in just one in 10 cardiac arrests where they are available, according ...

Lars Søndergaard joins Abbott’s structural heart business

Lars Søndergaard has left his role as professor of cardiology at Rigshospitalet, Copenhagen Universi...

Conformal Medical completes series D financing round

Conformal Medical has announced the successful completion of its series D funding round, raising...

First TAVI procedures performed using F2 cerebral embolic filter

EnCompass Technologies has announced its novel F2 cerebral embolic filter was used successfully in t...

Amazon executive joins Medtronic to spearhead development in robotics and implantables

Medtronic has announced that Ken Washington has been appointed chief technology and innovation offic...

First-in-man implant of “modular” TAVI device performed in Israel

Valve Medical, a wholly owned subsidiary of Medinol Ltd, has announced the first-in-human (FIH) impl...

ADVERTORIAL: Keeping stroke at bay for patients undergoing TAVI

This advertorial is sponsored by Boston Scientific Stroke—particularly disabling stroke—is among ...

MONITOR-HF trial results show improvement in quality of life scores for heart failure patients with CardioMEMS system

New data presented from an investigator-sponsored European trial found managing indicated heart fail...

Proprietary antioxidant complex shown to safeguard DNA from radiation exposure during aortic procedures

Cora Therapeutics has announced the presentation of the results of a clinical trial at the Canad...

SCAI 2023: Similar revascularisation rates seen with ticagrelor monotherapy and DAPT in TWILIGHT trial

Ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar...

HRS 2023: BIO-LIBRA study offers insights into device treatment of non-ischaemic cardiomyopathy

Preliminary results from the BIO-LIBRA study, assessing the outcomes of device-treated ventricul...

HRS 2023: SOLVE-CRT results “offer new hope for patients with hard-to-treat heart failure”

Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchroni...

Ruggero De Paulis

Inventor of the Valsalva aortic graft Ruggero De Paulis (European Hospital Unicamillus University, R...

Cardiovascular News – Issue 69 – May 2023: US Edition

In this issue: A new era for intracoronary imaging Top trials from ACC 2023 Profile: Rugg...

TVT registry analysis finds close to 90% success in mitral TEER procedures

A large registry study of patients undergoing transcatheter edge-to-edge repair (TEER) for degen...

HRS 2023: Researchers hope to use AI to “revolutionise” prediction of sudden cardiac death

AI
A novel artificial intelligence (AI) model correctly identified patients at near-term risk of sustai...

EuroPCR 2023: Global SYMPLICITY registry offers renal denervation insights out to three years

Analysis of the Global SYMPLICITY registry DEFINE (GSR DEFINE), presented at EuroPCR 2023 (16–19...

Finding the roots of the disease before treating it: Modelling NSTEMI

Paolo Contessotto (National University of Ireland Galway, Galway, Ireland) outlines his research dev...

SCAI 2023: No increased risk of hand dysfunction from distal compared to proximal radial artery access for cardiac procedures

A randomised controlled trial comparing the safety of distal versus proximal radial artery access fo...

SCAI 2023: Mechanical thrombectomy improves symptoms and quality of life in pulmonary embolism patients at six months

Six-month outcomes from FLASH registry have shown that patients with pulmonary embolism who were tre...

SCAI 2023: Two-year results “demonstrate strong clinical and haemodynamic outcomes” of Harmony transcatheter valve

Medtronic has announced two-year results for its Harmony transcatheter pulmonary valve (TPV) system,...

EuroPCR 2023: One-year BIOMAG-I results demonstrate safety and efficacy of resorbable scaffold platform

Results of the first-in-human study BIOMAG-I study, assessing Biotronik’s latest-generation Drea...

SCAI 2023: NACMI registry finds increased incidence of clotting among STEMI patients with COVID-19

Analysis from The North American COVID-19 STEMI (NACMI) registry, presented as late-breaking cli...

SCAI 2023: George Dangas begins term as SCAI president

The Society for Cardiovascular Angiography & Interventions (SCAI) has named George Dangas (I...

EuroPCR 2023: BIOADAPTOR trial shows non-inferiority of DynamX scaffold to DES for TLF at 12 months

Elixir Medical has announced that the BIOADAPTOR RCT trial of the company’s DynamX coronary drug...

EuroPCR 2023: Benchmark Registry data demonstrate improved TAVI efficiency

New data from the Benchmark Registry, a study of a streamlined transcatheter aortic valve implantati...

EuroPCR 2023: Carbon dioxide flushing prior to TAVI may offer protection against brain injury

A process of flushing prosthetic valves using carbon dioxide (CO2) prior to transcatheter aortic...

AATS 2023: COMMENCE aortic trial data shared through seven years

Edwards Lifesciences has announced new data from the COMMENCE aortic trial, demonstrating low ra...

EuroPCR 2023: Chimney stenting and BASILICA both seen to be effective in preventing TAVI-related coronary obstruction

A real-world comparison of two techniques aimed at reducing the risk of coronary obstruction aft...

EuroPCR 2023: Three-year EBC MAIN results demonstrate need for pragmatism in left main bifurcation stent strategy

Operators performing percutaneous coronary intervention (PCI) in bifurcation left main stem sten...

EuroPCR 2023: Imaging technology reduces contrast use during PCI

The use of an image-guidance system that overlays angiographic images on live fluoroscopic image...

Cardiovascular News – Issue 69 – May 2023: OUS Edition

In this issue: A new era for intracoronary imaging Top trials from ACC 2023 Profile: Rugg...

EuroPCR 2023: Robocath launches new robotic PCI platform

Robocath has announced the launch of its latest robotic platform—the R-One+. The company is showc...

Shockwave Medical’s C2+ coronary IVL catheter launched in select markets

Shockwave Medical has announced the full commercial availability of the Shockwave C2+ coronary intra...

Foldax acquires proprietary polymer patent family

Tria
Foldax has announced that it has executed an agreement with Australia’s national science agency,...

SavvyWire to be assessed in COMPLETE TAVR substudy

OpSens has announced the inclusion of SavvyWire in the COMPLETE TAVR clinical study to investigate t...

Turning extra pulses into pluses

This educational supplement, sponsored by Shockwave Medical, gains fresh perspective on the manageme...

More shocks for rocks

How has the new Shockwave C2+ catheter changed the treatment of calcified coronary lesions at He...

Managing eccentric and nodular calcium with IVL

Calcified nodules are frequently identified among coronary artery lesions and are associated wit...

The r(evolution) of calcium in Bristol

Tom Johnson (University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK) outlin...

ADVERTORIAL: Ongoing studies add to evolving understanding of TAVI valve durability

This advertorial is sponsored by Medtronic New data offer greater perspective on the long-ter...

ADVERTORIAL: Ready for the primetime? The future role of drug-coated balloons in PCI

This advertorial is sponsored by B Braun Melsungen AG “The evolution of PCI has always been a co...

US FDA expands indication for Farxiga

AstraZeneca’s Farxiga (dapagliflozin) has been approved in the USA to reduce the risk of cardiovascu...

First patient treated in head to head trial of TAVI embolic protection devices

Emboline has announced that the first patient has been treated in the Protect the Head to Head inves...

Handheld ECG device scoops CX 2023 Innovation Showcase prize

Judges of the CX 2023 Dragon’s Den-style contest — the finale of the Day 3 CX Innovation Showcas...

Study highlights disparity in TAVI outcomes based on availability

Research has highlighted significant regional variations in the availability of transcatheter ao...

Ultromics’ AI platform for detecting cardiac amyloidosis gains FDA breakthrough status

AI
Ultromics has been granted US Food and Drug Administration (FDA) breakthrough device status for its ...

Carillon mitral contour system gains EU MDR certification

Cardiac Dimensions has announced that its Carillon mitral contour system, for the treatment of f...

CAAS Qardia gains Japanese certification

Pie Medical Imaging has received NINSHO Medical Device Certification for CAAS Qardia, its echocardio...

First US implant of Lux-Valve Plus transcatheter tricuspid valve performed in Detroit

The first transcatheter tricuspid valve replacement procedure in the USA using the LuX-Valve Plu...

Shockwave Medical completes Neovasc acquisition

Shockwave Medical has announced the completion of its previously announced acquisition of Neovas...

OpSens completes European enrolment in SAFE-TAVI study

OpSens has announced the successful completion of enrolment in the SAFE–TAVI clinical study, studyin...

Cardiovascular News’ top 10 stories of March 2023

The news agenda in March was dominated by late-breaking data from the American College of Cardiology...

Research project to determine how stretching and blood flow impact engineered heart valves

New research will investigate how stretching and blood flow can inhibit or encourage cardiovascu...

Medtronic launches technology aimed at simplifying MRI screening for patients with implanted cardiac devices

Medtronic has announced the launch of MRI Care Pathway, a new system designed to streamline the proc...

PROACTIVE-HF pivotal trial completes enrolment

Endotronix has announced its PROACTIVE-HF pivotal study has successfully completed enrolment. ...

Smart glasses guide remote support for pioneering TAVI procedure

The UK’s first remotely-supported transcatheter aortic valve implantation (TAVI) using smart glasses...

Enrolment target met in ECLIPSE coronary atherectomy trial

Cardiovascular Systems has announced the complete enrolment of its 2,000-patient ECLIPSE coronar...

Experts update consensus on left atrial appendage closure

The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Socie...

Abbott’s Epic Max stented tissue aortic valve gains US FDA approval

remote monitoring
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's E...

Azeem Latib joins Supira Medical as medical director

Supira Medical has announced the appointment of Azeem Latib (Montefiore Health Systems, New York...

ADVERTORIAL: “No stroke is innocent”: Why stroke matters for TAVI patients

This advertorial is sponsored by Boston Scientific Today there are more than 75,000 transcatheter...

PADN-5 study results “exciting” for pulmonary artery denervation in heart failure and CpcPH patients

Results from the PADN-5 study, investigating the efficacy and safety of pulmonary artery denerva...

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Saranas has announced that it has reached the midpoint for enrolment in SAFE-MCS, a multicentre, sin...

Thousandth patient enrolled in SELUTION DeNovo coronary study

MedAlliance has announced enrolment of over 1,000 patients in its SELUTION DeNovo coronary randomise...

Immediate revascularisation non-inferior to staged procedure in acute coronary syndrome and multivessel disease

Immediate, complete revascularisation with percutaneous coronary intervention (PCI) in patients ...

Robotic electrophysiology programme opens in south eastern USA

Stereotaxis has announced the opening of a new robotic electrophysiology programme at Broward He...

BIOMAG-I study demonstrates low rate of in-scaffold late lumen loss at six months

Angiographic and clinical data from the BIOMAG-I clinical study, presented at the 2023 Cardiovas...

US FDA approval for Essenz heart-lung machine

LivaNova has announced the receipt of US Food and Drug Administration (FDA) 510(k) clearance for its...

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Assessing myocardial viability does not aid the selection of patients who will benefit—or not—fr...

Cardiovascular News’ top 10 stories of February 2023

February’s trending topics included a look at the past, present and future of transcatheter aortic v...

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

Edwards Lifesciences has highlighted new data examining mortality rates and cardiac damage of ea...

EU ministers approve changes to MDR transition timetable

The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for ...

ACC 2023: Pulsed AF trial yields “promising” safety and efficacy results for PFA system

Results of the Pulsed AF Pivotal trial, investigating pulsed field ablation (PFA) treatment in p...

ACC 2023: Equivalent recovery times shown between minimally invasive and conventional surgery for mitral valve repair

The largest randomised controlled trial to date to compare minimally invasive and conventional c...

Neovasc shareholders approve acquisition by Shockwave Medical

Neovasc has announced that its shareholders have approved the previously-announced acquisition o...

ACC 2023: Intravascular imaging bests angiography guidance in trial of PCI in complex lesions

Use of intravascular imaging guidance for percutaneous coronary intervention (PCI) in patients with ...

ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients

Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with ...

ACC 2023: MitraClip meets endpoints at five years in COAPT trial

Final, five-year clinical outcomes from the COAPT trial, evaluating transcatheter mitral valve r...

ACC 2023: Benefit of TAVI “consistent” over first three years in low risk patients

Three-year results from the Evolut Low Risk trial have shown “durable” benefits of transcatheter...

ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial

Hotly-anticipated results of the randomised TRILUMINATE pivotal trial, presented during the 2023...

Preclinical model could aid future research of NSTEMI therapies

Researchers have detailed a new preclinical model for non-ST elevation myocardial infarction (NSTEMI...

HyperVue intracoronary imaging system gains US FDA approval

SpectraWAVE has announced US Food and Drug Administration (FDA) 510(k) clearance of its flagship int...

CRT 2023: Abbott shares new data on Navitor TAVI and Amplatzer Amulet LAAO systems

Results from the PORTICO NG study of Abbott’s Navitor transcatheter aortic valve implantation (TAVI)...

Five-year durability analysis of CoreValve and Evolut platforms “underscores long-term promise of TAVI”

Five-year bioprosthetic valve dysfunction data for Medtronic’s CoreValve and later-generation Ev...

Results of cell therapy trial in patients with heart failure due to low EF published in JACC

Results of a trial involving cell therapy in patients with chronic heart failure due to low ejec...

CONFORMAL EFS study results presented at CRT 2023

Results from the CONFORMAL early feasibility study (EFS), evaluating the use of angiography comp...

Risk model adds to prediction tools for surgical risk in adult congenital heart disease patients

A model designed to predict surgical risk in the setting of adult congenital heart disease (ACHD) im...

Medtronic welcomes ESC and EAPCI renal denervation consensus statement

Medtronic has welcomed the publication of the consensus statement on renal denervation issued by the...

First patient treated in A PRIORI pilot trial of Aortix circulatory support device

complete-revascularisation
Procyrion has announced the successful treatment of the first patients in the A PRIORI—Aortix therap...

Medtronic relaunches Harmony transcatheter pulmonary valve

Medtronic has announced the relaunch of its Harmony transcatheter pulmonary valve (TPV) system, a mi...

Barostim misses primary endpoint in BEAT-HF postmarket trial

CVRx has announced the preliminary topline results of the BeAT-HF—Baroreflex activation therapy for ...

US FDA clears tool to rapidly analyse RV/LV ratio

RapidAI announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid R...

Renal denervation “can reach new shores”

The publication of a consensus statement from the European Society of Cardiology (ESC) Council o...

Teleflex grows catheter portfolio following US FDA approval

Teleflex Incorporated has today announced key milestones in the release of two new catheters, includ...

Xeltis secures funding to progress clinical trials

Xeltis has raised €32 million in a Series D2 equity fundraise, backed by a syndicate of current and ...

ACC, AHA and SCAI lay roadmap for interventional cardiology training

The American College of Cardiology (ACC), the American Heart Association (AHA) and the Society for C...

ESC and EAPCI publish renal denervation consensus statement

SonieVie
Renal denervation represents another treatment option in patients with uncontrolled resistant hypert...

COPS trial shows feasibility of using a cutting balloon at high pressure to modify calcium prior to PCI

Attendees of the 2023 Joint Interventional Meeting (JIM, 9–11 February, Milan, Italy) heard results ...

OPN NC “super-high-pressure” coronary balloon launches in USA

SIS Medical AG has announced the launch of its OPN NC percutaneous transluminal coronary angioplasty...

GE HealthCare to acquire AI ultrasound developer Caption Health

GE HealthCare has signed an agreement to acquire Caption Health, a developer of artificial intel...

ADVERTORIAL: DCB therapy offers a glimpse of interventional cardiology’s past and future

This advertorial is sponsored by Cardionovum “Everything started with balloon inflations in t...

Home-based therapy can help to reduce anxiety and depression in cardiovascular patients

A randomised study led by Greater Manchester Mental Health NHS Foundation Trust (GMMH) and the U...

Cardiovascular News 68 – February 2023: US Edition

In this issue: Medicare study reopens guideline debate around surgery and PCI in patients with ...

Cardiovascular News 68 – February 2023: OUS Edition

In this issue: Medicare study reopens guideline debate around surgery and PCI in patients with ...

ADVERTORIAL: A step forward in scoring balloon catheter design

This advertorial is sponsored by iVascular A new coronary scoring balloon dilatation catheter...

Automated alert tool “associated with a small decrease in contrast use” during PCI

Performance improvement company Biome Analytics has announced the publication of a study in Circulat...

TruLeaf Medical to trial “two-stage” TMVR platform

TruLeaf Medical is to conduct a first-in-human clinical trial of a “two-stage” transcatheter mit...

PCI can be performed as safely without on-site access to surgery, says SCAI

Percutaneous coronary intervention (PCI) without on-site surgical support is as safe as PCI at centr...

Cardiovascular-aortic community comes together at CX 2023

From cutting-edge aortic interventions to consensus on revascularisation strategies in the periphera...

ADVERTORIAL: A wealth of data underscore treatment choices for coronary DCBs

This advertorial is sponsored by B. Braun Melsungen AG The modern field of percutaneous coron...

First patient treated in LeAAPS trial of left atrial appendage occlusion in cardiac surgery patients

AtriCure has announced that the first patient was treated in the LeAAPS clinical trial, a prospectiv...

Slow progress made on gender balance in cardiovascular trial leadership

Little progress has been made over the last decade in improving gender balance in leadership positio...

Nieves Gonzalo

Interventional cardiology is a rapidly evolving field, offering the opportunity to learn procedures ...

Medicare study reopens guideline debate around surgery and PCI in patients with multivessel coronary artery disease

An analysis of data from more than 100,000 patients with multivessel coronary artery disease und...

First US patient enrolled into study of Selution SLR coronary drug-eluting balloon

The first US patient has been enrolled at Medstar Washington Hospital Center (Washington DC, USA) in...

STS 2023: Risk assessment tool “sets a high bar” when considering alternatives to surgery in mitral valve repair

A new risk assessment tool has been produced to provide a comprehensive method for assessing ope...

Enrolment milestone reached in trial of angiography-based vessel fractional flow reserve in coronary revascularisation

Pie Medical Imaging has announced the enrolment of the 500th patient in the FAST III clinical trial,...

Trial of super saturated oxygen therapy after PCI begins enrolment

Zoll has announced that the first patient has been enrolled in the REAL SSO2 post-market observation...

Registry data point to a declining rate of complications among primary MR patients

The largest dedicated registry on mitral transcatheter edge-to-edge repair (M-TEER) in primary m...

Shockwave agrees to acquire Neovasc

Shockwave Medical has entered into a definitive agreement to acquire Neovasc Inc, developer of t...

US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients

The US Food and Drug Administration (FDA) has approved the Navitor (Abbott) transcatheter aortic val...

Effects of short DAPT “consistent regardless of high bleeding risk and complex PCI”

Research evaluating the effects of high bleeding risk (HBR) and complex percutaneous coronary interv...

Pie Medical Imaging announces launch of CAAS Qardia 2.0 echocardiography software platform

Pie Medical Imaging has launched a new version of its echocardiography software platform—CAAS Qardia...

NICE lowers threshold for statins to prevent cardiovascular events

The UK’s National Institute for Health and Care Excellence (NICE) has published draft guidance recom...

HVR Cardio closes €10.7 million series B funding round

HVR Cardio has closed on a €10.7 million series B round of financing. The Series B Round was led...

Depression increases likelihood of non-adherence to medical therapy post-PCI

Patients with depression were 10–20% less likely to adhere to guideline-directed medical therapy aft...

Multidisciplinary teams at the heart of new guidelines on aortic disease management

Closer ties between cardiologists, cardiac surgeons and vascular surgeons will be a hallmark of the ...

MedAlliance’s Selution SLR receives coronary de novo IDE approval

Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional US Food and Dr...

Preclinical study outlines key features of foam-based LAA closure device

A preclinical study demonstrating key features of the foam-based left atrial appendage closure d...

Cardiac Dimensions closes funding round to support US EMPOWER pivotal study

Cardiac Dimensions has closed a US$35 million Series D financing round. The financing was co-led...

Funding secured to advance development of Pulse IVL system

AVS has announced that it raised US$20 million in Series B financing, which the company says will ac...

Cardiovascular News’ top stories of 2022

Which stories, features and interviews captured the attention of the cardiovascular community across...

SCAI announces recipients of early career grant scheme

The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the four recipie...

No sex difference seen in outcomes for transcatheter tricuspid valve intervention

Transcatheter tricuspid valve intervention is associated with similar outcomes in both women and...

ReCor appoints Lara Barghout to lead commercialisation of Paradise renal denervation system

ReCor Medical and its parent company Otsuka Medical Devices have announced the appointment of La...

Enrolment begins in trial to assess new therapy in patients deemed unsuitable for anticoagulants

Anthos Therapeutics has announced that it has enrolled the first patient in LILAC-TIMI 76, a pha...

Johnson & Johnson completes Abiomed acquisition

Johnson & Johnson has today announced it has completed its acquisition of Abiomed. Abiomed is no...

Machine learning enables “clinically important” characterisation of coronary artery disease

Using machine learning and clinical data from electronic health records, researchers have constructe...

Stem cell plasters “could revolutionise treatment of congenital heart disease”

Researchers have developed ‘stem cell plasters’ which it is hoped will revolutionise the way sur...

Enrolment begins in Impella ECP pivotal trial after US FDA green light

The first two patients have been enrolled in the Impella ECP pivotal trial, after the US Food an...

STAR-T trial of antithrombotic removal system during cardiac surgery to continue

CytoSorbents Corporation has received the recommendation from the independent Data and Safety Mo...

First US procedure performed using ShortCut leaflet splitting device

Pi-Cardia has announced that the first patient in the USA has been successfully treated with ShortCu...

Cardiology societies urge rethink of randomised controlled trial design

The current model for randomised clinical trials must be redesigned for the modern age, according to...

Pilot study of wire pacing sleeve yields positive results in TAVI and PCI procedures

A first-in-human trial using a purpose-built device to provide direct wire pacing without the need f...

Corindus rebrands to Siemens Healthineers Endovascular Robotics

Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedi...

EU Commission to propose delay to MDR implementation

Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the tran...

UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction

AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...

TRICares secures financing to fund development of Topaz tricuspid valve replacement system

TRiCares has announce the second closing and completion of its Series C financing round, successfull...

First patient randomised in RESPONDER-HF trial of Corvia atrial shunt

Corvia Medical has announced that the first patient has been randomised in RESPONDER-HF, a globa...

ESC warns of cardiac device shortage due to implementation of MDR regulations in Europe

The European Society of Cardiology (ESC) has urged European Union (EU) health ministers to act to pr...

Postmarket data point to lower rates of PVL with Acurate neo2 TAVI valve

The addition of an annular sealing skirt, among other design changes in the Acurate neo2 transca...

TRISCEND trial reports one-year outcomes in patients undergoing transcatheter tricuspid valve implantation

Stephan Windecker (left) presents one-year outcomes from the TRISCEND study
One-year results from the TRISCEND study, investigating the Evoque (Edwards Lifesciences) tricus...

ADVERTORIAL: TAVI valve durability and reliability: How patient lifetime management is evolving

This advertorial is sponsored by Medtronic Durability, reliability, accuracy. These are just ...

DurAVR heart valve system gets green light from US FDA for early feasibility study

Anteris Technologies has announced that the US Food and Drug Administration (FDA) has conditionally ...

First implant of MonarQ tricuspid valve replacement system performed in Copenhagen

inQB8 Medical Technologies, in partnership with Peijia Medical, has announced first successful i...

Nyra Medical secures investment for transcatheter mitral valve repair technology

Nyra Medical has announced the closing of a US$20 million Series A financing. The round was c...

First-in-human procedure performed using Impella RP Flex

The first implant procedure using the Impella RP Flex (Abiomed) percutaneous pump, following its rec...

Late-breaking Xlimit randomised trial data shared at CSC 2022 congress

Data presented at an innovation session at the 2022 Structural and Coronary Intervention Course  (CS...

Timothy D Henry

A pioneer of one of the first regional ST-segment elevation myocardial infarction (STEMI) systems in...

Carmat resumes commercial implants of Aeson artificial heart

Carmat has announced the resumption of commercial implants of its Aeson total artificial heart. C...

CroíValve reports successful first in human implants of its Duo tricuspid coaptation valve system

CroíValve has announced the successful first in human implants of its Duo tricuspid coaptation v...

Cardiovascular News 67 – November 2022: OUS Edition

In this issue: Latest evidence from key renal denervation trials REVIVED-BCIS 2: PCI fails t...

Cardiovascular News 67 – November 2022: US Edition

In this issue: Latest evidence from key renal denervation trials REVIVED-BCIS 2: PCI fails t...

Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND

Extended follow-up of the ISCHEMIA-EXTEND trial has shown no difference in rates of all-cause mo...

AI system to aid decision making for aortic aneurysm treatment

viz series d
Viz.ai has announced a partnership with Illuminate, a developer of proprietary natural language proc...

Use of clinical support platform “reduces risk of kidney injury” from PCI

Patients at high risk for acute kidney injury (AKI), the most common complication of percutaneous co...

RELIEF clinical study to assess use of Cardioform septal occluder for migraine relief

WL Gore & Associates has announced that it is initiating the RELIEF clinical study—an invest...

Neovasc Reducer assigned outpatient reimbursement code from CMS

Neovasc has announced that the Centers for Medicare and Medicaid Services (CMS) has assigned the Neo...

New surgical thresholds and need for multidisciplinary teams reflected in revised aortic guidelines

The American College of Cardiology (ACC) and American Heart Association (AHA) have jointly published...

Johnson & Johnson reaches agreement to acquire Abiomed

Johnson & Johnson is to acquire Abiomed, it was announced today, after the two organisations ent...

Impella RP Flex with SmartAssist receives US FDA approval to treat right heart failure

Abiomed has announced that Impella RP Flex with SmartAssist has received US Food and Drug Administra...

Carmat gains approval to resume clinical study of total artificial heart

Carmat, developer of the Aeson total artificial heart, has announced that it has been granted th...

US FDA accepts post-approval study reports for Impella

Abiomed has announced the US Food and Drug Administration (FDA) has accepted and closed the post...

First patients treated in SAFE-TAVI clinical study

OpSens Medical has announced the successful completion of the first cases in a clinical study—SAFE-T...

Selution SLR receives US FDA investigational device exemption approval for coronary clinical trial

Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received US Food and Drug Administr...

Ticagrelor after CABG associated with a decreased risk of vein graft failure compared to aspirin

In patients undergoing coronary artery bypass graft (CABG) surgery, the addition of ticagrelor t...

LeAAPS trial to explore benefit of left atrial appendage occlusion in cardiac surgery patients at risk for stroke

Researchers are to investigate the safety and efficacy of performing left atrial appendage occlu...

AccurKardia and Mawi link up to add automated ECG analytics for the new Mawi Watch

AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocard...

HeartFlow receives US FDA approval for Plaque and RoadMap analysis AI products

HeartFlow has received US Food and Drug Administration (FDA) 510(k) clearance on two new, AI-pow...

MedAlliance to be acquired by Cordis

MedAlliance is to be acquired by Cordis, it was announced today, after the two companies reached agr...

Rates of stroke and embolism lower with apixaban compared to rivaroxaban

In a large, population-based study of patients with atrial fibrillation (AF) and valvular heart dise...

Abiomed gains FDA approval for Impella low profile sheath

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed to market a ne...

Swedish registry data point to survival benefit for younger patients undergoing CABG

An analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) has s...

Analysis shows survival benefit in high-risk PCI supported by Impella

An analysis of more than 2,000 patients from a large US real-world database finds that patients ...

Swedish and Dutch organisations agree to research collaboration

The Uppsala Clinical Research Center (UCR) and the European Cardiovascular Research Institute (E...

Minimally invasive aortic perfusion cannula receives EACTS Techno-College innovation award

The developers of a cannula for minimally-invasive central aortic perfusion—MIC-Cannula—received...

CathWorks gains Japanese regulatory approval for FFRangio system

CathWorks has announced approval of the fourth generation CathWorks FFRangio system by the Japan...

EACTS 2022: Global studies will fill gap for “high-quality evidence” on invasive treatment of ischaemic cardiomyopathy

A global research initiative will compare coronary artery bypass graft surgery (CABG) and percut...

EACTS 2022: “Wake up call” for trialists over gender balance

Clinical trials in cardiothoracic surgery must ensure that sufficient numbers of women are enrol...

Latest data underscore optimism for future of renal denervation

Ajay Kirtane (Columbia University Irving Medical Center New York-Presbyterian Hospital, New York...

Long-term P2Y12 monotherapy after PCI “may be a promising strategy”

Three-year outcomes from the SMART-CHOICE trial have shown that P2Y12 inhibitor monotherapy was asso...

Enrolment completed in trial comparing PCI in diabetic patients

ABILITY DIABETES-GLOBAL, a randomised controlled head-to-head trial comparing safety and efficacy of...

Puzzle Medical wins 2022 TCT Shark Tank innovation competition

Puzzle Medical Devices was announced as the winner of the Shark Tank innovation competition at the 2...

Rivaroxaban may be an option for reducing radial artery occlusion in transradial coronary procedures

The use of rivaroxaban for seven days after a transradial coronary procedure reduced the rate of...

Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients

Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To...

First US TAVI procedure performed using SavvyWire guidewire

OpSens has announced that Philippe Genereux (Morristown Medical Center, Morristown, USA) has perform...

Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022

Biotronik has announced the presentation of new full-cohort two-year BIOSOLVE-IV data. In a post...

FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI

Medtronic has received Food and Drug Administration (FDA) approval for the treatment of non-left mai...

Clinical trial of TAVI in severe aortic regurgitation completes enrolment

JenaValve Technology has announced the successful completion of patient enrolment in the ALIGN-AR Pi...

TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation

Analysis of data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) ...

TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures

Results from a multicentre randomised trial comparing ultrasound with fluoroscopic guidance vers...

Medtronic expands US rollout of Evolut FX TAVI system

Medtronic has announced the expanded US market release of its newest-generation, self-expanding tran...

Shockwave initiates all female coronary IVL registry study

Shockwave Medical has initiated a prospective coronary intervention study consisting of all female p...

Breakthrough device designation granted for SirPlux Duo coronary DCB in small vessels

Advanced NanoTherapies has been granted US Food and Drug Administration (FDA) breakthrough devic...

TCT 2022: Amulet occluder keeps pace with Watchman at three years

Long-term follow-up of patients with non-valvular atrial fibrillation (AF) receiving the Amplatz...

TCT 2022 hears “important data” from renal denervation trials

Findings from the RADIANCE II randomised pivotal trial, presented at the 2022 Transcatheter Card...

TCT 2022: Valentin Fuster receives career achievement award

The major contribution of Valentin Fuster (Mount Sinai Health System, New York, USA) to the fiel...

TCT 2022: Pascal non-inferior to MitraClip in head-to-head trial in degenerative MR patients

The first randomised trial to compare two transcatheter edge-to-edge repair (TEER) devices —CLAS...

TCT 2022: No difference in rates of post-TAVI stroke seen with cerebral embolic protection device in PROTECTED TAVR

Among patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) the use of...

US FDA grants 510(k) clearance for SavvyWire TAVI guidewire

OpSens has received 510(k) regulatory clearance from the US Food & Drug Administration (FDA) for...

Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser

The 2022 Transcatheter Cardiovascular Therapeutics (TCT, 16–19 September, Boston, USA) opened wi...

Abiomed given green light for RECOVER IV randomised trial

Abiomed has announced two approvals from the US Food and Drug Administration (FDA) related to clinic...

Cardiac Implants announces successful adjustment procedure using its Tri-Ring device to treat TR

Cardiac Implants has announced the successful initial deployment of its annuloplasty ring with imple...

Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB

Concept Medical has announced the successful completion of the TRANSFORM 1 RCT. The randomised c...

TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude

A budget impact analysis comparing transcatheter aortic valve implantation (TAVI) with surgical ...

Vascade vascular and venous closure devices gain CE mark

Haemonetics Corporation has received CE mark certification for its Vascade vascular closure and ...

Latest Sapien TAVI valve features anti-calcification technology

Edwards Lifesciences has announced the launch of the Sapien 3 Ultra Resilia valve—combining Edwards’...

Three-year data “reinforce safety and efficacy” of Abbott’s Amplatzer Piccolo in infants with PDA

Abbott has announced three-year data for its Amplatzer Piccolo occluder for the treatment of patent ...

The time for change is now: Call for action over “ageing and unbalanced” cardiothoracic surgery community

Analysis of the global make-up of the four largest global societies for cardiothoracic surgery sugge...

Results of cuffless blood pressure monitor presented at AHA Hypertension Sessions

Results of an analysis of Aktiia’s cuffless blood pressure (BP) monitoring system are being presente...

First patient joins study of SSO2 therapy post-PCI

Zoll Medical has announced that the first patient has been enrolled in the AMIHOT III post-approval ...

Abbott’s Amplatzer Talisman PFO occlusion system launched in Europe

Abbott has announced the European launch of its Amplatzer Talisman patent foramen ovale (PFO) occlus...

AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal AF

AtriAN Medical has announced that it has completed enrolment of a second study using its selective p...

Tom Nguyen

As a proponent of minimally invasive cardiac surgery and transcatheter techniques, Tom Nguyen (Unive...

Cardiovascular News’ top 10 most popular stories of August 2022

The most read stories from across Cardiovascular News in August 2022 include highlights from the Eur...

FDA clears Viz.ai’s right-to-left ventricle ratio algorithm

Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for an automated right ve...

Latest centre begins using Philips’ Verisight Pro 3D intracardiac echocardiography catheter

Royal Philips has announced that Baptist Health’s Miami Cardiac & Vascular Institute (Miami, USA...

New DAPT labelling approved for Watchman FLX device

Boston Scientific has received US Food and Drug Administration (FDA) approval to expand the inst...

First patient enrolled in Hyper II study evaluating hybrid approach in long diffuse CAD

Cardionovum has announced the enrolment of the first patient in the international Hyper II clini...

JenaValve raises US$100 Million to advance Trilogy TAVI system

JenaValve Technology has announced that it has completed the initial closing of a US$100 million Ser...

ESC 2022: Risk score predicts mortality for AF patients after TAVI

Researchers have developed a risk score to predict mortality for patients with atrial fibrillati...

ESC 2022: Survival benefit seen following use of Abbott’s HeartMate 3 LVAD

Abbott has announced the release of late-breaking showing that its HeartMate 3 heart pump extend...

ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures

Transradial access for percutaneous coronary procedures is associated with lower rates of all-ca...

ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI

Fifteen-month results from the MASTER DAPT trial have shown that the preserved ischaemic benefit...

ESC 2022: Kidney disease patients with coronary disease see no improvement in survival at five years with an invasive approach

In patients with advanced chronic kidney disease (CKD) and chronic coronary disease, an invasive...

ESC 2022: FRAME-AMI sheds light on best strategy for selecting non-infarct lesions for PCI

Selection of non-infarct related artery (IRA) lesions for intervention using fractional flow res...

ESC 2022: High-risk aortic stenosis could be picked up using AI

Late-breaking research presented at the European Society of Cardiology (ESC) annual congress (26...

ESC 2022: POST-PCI trial finds no benefit to routine functional testing in high-risk PCI patients

Among high-risk patients undergoing percutaneous coronary intervention (PCI), a follow-up strate...

ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT

Results of one of the first and only randomised, blinded trials to assess the use of an artifici...

ESC 2022: REVIVED data show PCI does not benefit patients with severe left ventricular dysfunction

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ho...

ESC 2022: SECURE trial finds “polypill” results in lower risk of cardiovascular events compared to usual care

Use of a ‘polypill’ after myocardial infarction (MI)—an all-in-one pill containing an antiplatel...

ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes

The timing of dosing of antihypertensive medication—whether it is taken in the morning or in the...

Programme released for TCT MedTech Innovation Forum

The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the programme...

Medtronic launches Onyx Frontier coronary stent following CE mark approval

Medtronic has announced the launch of its latest generation drug-eluting coronary stent—Onyx Frontie...

Cardiovascular News 66 – August 2022: OUS Edition

In this issue: Call for action over age and gender profile of global cardiothoracic surgery com...

Cardiovascular News 66 – August 2022: US Edition

In this issue: Call for action over age and gender profile of global cardiothoracic surgery com...

Miracor’s PiCSO technology approved by FDA for investigational device exemption study

Miracor Medical has announced the approval of an investigational device exemption (IDE) from the...

First-in-human procedure completed using ShortCut Mitral device

Pi-Cardia has announced a successful first-in-human treatment of the mitral valve with the ShortCut ...

Edwards gains CE mark for Pascal Precision system for mitral and tricuspid regurgitation

Edwards Lifesciences has announced that the company's Pascal Precision transcatheter valve repai...

Restore EF study “shows heart function, symptom improvements” for high-risk PCI patients supported by Impella

Abiomed  has announced the results of the Restore EF study, demonstrating that Impella-supported hig...

CX Aortic Vienna: Cardiac and vascular surgeons collaborate at the vanguard of aortic care

CX Aortic Vienna
CX Aortic Vienna returns in October for its third edition (24–26 October, Digital), bringing togethe...

AHA and CRF announce collaborative education programme

The American Heart Association (Association) and the Cardiovascular Research Foundation (CRF) have a...

Spotlight turns to TAVI in patients with moderate aortic stenosis

Ongoing clinical trials looking at transcatheter aortic valve implantation (TAVI) for patients w...

Cardiovascular News’ top 10 most popular stories of July 2022

The most read stories from across Cardiovascular News in July 2022 include reflections on the future...

“Worrisome” rise in cardiovascular disease predicted out to 2060

Projected rates of cardiovascular risk factors and disease will increase significantly in the USA by...

“Positive” 30-day outcomes for patients receiving Optimum transcatheter aortic valve

Thubrikar Aortic Valve has announced successful 30-day outcomes in the first two patients receiving ...

Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine

Cardiac surgeons from North America, Europe and Latin America are among the signatories to a multidi...

Genetic “cure” for cardiomyopathy is selected as winner of Big Beat Challenge

A project to develop genetic therapies to effectively cure cardiomyopathy has been announced as ...

Three-year results of RANGO registry presented at EuroPCR

iVascular has announced the release of three-year observational data concerning its Angiolite cobalt...

Neovasc gains approval for protocol supplement to COSIRA-II trial

Neovasc has announced that the US Food and Drug Administration (FDA) has approved a protocol sup...

Digital drainage system for cardiac surgery “safe and effective”

Centese has announced the publication of the first peer-reviewed clinical study of its Thoraguard di...

Pi-Cardia gains FDA nod for study of ShortCut leaflet splitting device

Pi-Cardia has received Investigational Device Exemption (IDE) approval from the US Food and Drug Adm...

Ultrasound renal denervation meets primary efficacy endpoint in RADIANCE II study

ReCor Medical and Otsuka Medical Devices have announced that the RADIANCE II US Food and Drug Admini...

Steps needed to include disadvantaged patients in mitral and tricuspid trials

Incentives for the enrolment of patients from socieconomically disadvantaged groups, as well as ...

Cathbot completes enrolment in clinical study of robotic-assisted PCI in China

Cathbot—a joint venture between Robocath and MicroPort—has enrolled the last patient in its clinical...

Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI

Preventing coronary obstruction after transcatheter aortic valve implantation (TAVI) becomes inc...

New funding for research to examine use of blood pressure cuffs for heart failure patients with pacemakers

A research project at the University of Leeds (Leeds, UK) aiming to find an easier way to establ...

FDA grants breakthrough status for Accucinch ventricular restoration system

Ancora Heart has announced that the US Food and Drug Administration (FDA) has granted Breakthrou...

First patients enrolled in study of Booster spiral balloon therapy for acute myocardial infarction

Intratech Medical has announced the successful enrolment of two patients in a multicentre first-in-h...

VenusP-Valve gains approval from China’s NMPA

VenusP-Valve
The VenusP-Valve (Venus Medtech) transcatheter pulmonic valve replacement (TPVR) system has been...

Stress testing can guide patient selection for coronary revascularisation

Patients identified by nuclear stress testing as having severe stress-induced myocardial ischaem...

Echocardiographers face “under-recognised” radiation exposure risk in the cath lab

Echocardiographers may be at significantly greater risk of exposure to radiation than interventional...

TCT MedTech Innovation Forum to spotlight opportunities for innovation

The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the launch of the...

Analysis shows “positive trend” with thinner strut stents in patients with small vessels

A subgroup analysis of the BIO-RESORT trial has shown a “trend towards better outcomes” with thi...

HeartBeam expands software platform to cover unstable angina

HeartBeam is expanding the available patient population for its emergency department software techno...

Cardiovascular News’ top 10 most popular news stories of June 2022

The most read stories from across Cardiovascular News in June 2022 include highlights from TVT 2022 ...

Female representation in interventional cardiology remains low, but there is cause for hope

Suzanne Baron and Ki Park detail some of the barriers facing women in the field of interventiona...

Advanced NanoTherapies closes Series A funding round

Advanced NanoTherapies has closed a US$7.2 million Series A equity financing round marking a tot...

EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients

Results from the first commercial implants of the Trilogy transcatheter aortic valve implantatio...

First patients enrolled in Manta Ultra vascular closure device study

Teleflex has announced the first patient enrolment in a clinical study that is intended to demon...

AF after surgery is linked to an increased risk of heart failure hospitalisation

People who develop an arrhythmia after surgery have an increased risk of subsequently being admitted...

Acutus launches expanded suite of left-heart access products

Acutus Medical has announced the commercial launch of an expanded suite of left-heart access pro...

CABG “associated with favourable outcomes and increased long-term survival” among octogenarians

A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochester, USA) has found t...

CONFORM pivotal trial of CLAAS system begins enrolment

Conformal Medical has announced the launch of the CONFORM pivotal trial with the enrolment of th...

TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens

Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO) using the Watchman...

TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device

Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston Scientific) device ...

TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria

Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip treatment in secondar...

TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”

Data from the first report on patients with a pacemaker lead across the tricuspid valve have sho...

First patient treated in HEAL-IST clinical trial

AtriCure has announced that the first patient has been treated in the HEAL-IST trial, evaluating the...

Patients with mitral annulus calcification at higher risk of mitral valve dysfunction

A retrospective review of more than 24,000 patients who underwent an electrocardiogram (ECG) has fou...

First-in-human results of Captis embolic protection device presented at EuroPCR 2022

Filterlex Medical has announced results from a first-in-human (FIH) study demonstrating the safe...

Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care

A study has revealed the “global collateral damage” caused by the disruption to cardiac services cau...

UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year

Transcatheter aortic valve implantation (TAVI) was found to be non-inferior to surgery for all-c...

EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies

The use of distal radial artery access for percutaneous coronary intervention (PCI) comes at the...

AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure

Concurrent tricuspid valve surgery and left ventricular assist device (LVAD)  implantation did n...

SCAI 2022: Analysis looks at coronary IVL outcomes in women and men

New data confirming one-year outcomes with coronary intravascular lithotripsy (IVL, Shockwave Me...

SCAI names Sunil Rao as incoming president

Sunil Rao (Duke University Health System, Durham, USA) has assumed the office of president of th...

Cordella meets safety and efficacy endpoints in SIRONA 2 clinical trial

Endotronix has announced data from the SIRONA 2 clinical trial evaluating safety and efficacy of...

EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study

One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Edwards Lifesciences) ...

EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique

Use of the cusp overlap technique for the deployment of devices in transcatheter aortic valve im...

EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety

Results of the 20-patient, first-in-human clinical study supporting the safety and efficacy of the S...

EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed

Patients in England with ST-elevation myocardial infarction (STEMI) had an average loss of 1.86 ...

SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”

Analysis of data from a US-wide health system suggests that the volume of percutaneous coronary inte...

Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022

Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, France) focused on th...

EuroPCR 2022 hears new data on robotic PCI

New data on robotic-assisted percutaneous coronary intervention (PCI) have been presented during a l...

EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity

Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR 2022 (17–20 May, Pa...

EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension

Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France) underscore the pot...

Medtronic gains FDA approval for Onyx Frontier drug-eluting stent

Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for the ...

Cardiovascular News 65 – May 2022: US Edition

In this issue: New data hint at positive performance of TAVI on structural valve durability ...

Cardiovascular News 65 – May 2022: OUS Edition

In this issue: New data hint at positive performance of TAVI on structural valve durability ...

Analysis charts “significant” growth of US TEER procedures since 2012

A US analysis comparing trends in transcatheter and surgical mitral valve repair (SMVR) has found a ...

Abbott funds programme to boost diversity in clinical trial leadership

Abbott has announced a new partnership with Women as One to launch a new programme designed to train...

Vijay Kunadian

Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastl...

ADVERTORIAL: Cath lab technologies for medicine in the precision age

This advertorial is sponsored by Siemens Healthineers In the modern cath lab, having a suite of t...

ADVERTORIAL: TAVI valve durability under the microscope

This advertorial is sponsored by Medtronic Due to the growth of transcatheter aortic valve im...

Cardiovascular News’ top 10 most popular stories of April 2022

The most read stories from across Cardiovascular News in April 2022 include highlights and late-brea...

DCB in PCI: Adjunctive therapy or standard of care?

This educational supplement, sponsored by Medtronic, explores the science underpinning the use of dr...

“TAVI was my baby, now it is a teenager”

In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 is a landmark date, ...

Health Canada approval granted for SavvyWire TAVI guidewire

OpSens has announced that it has received Health Canada approval for the SavvyWire, its new guidewir...

Japanese and US regulatory approvals granted for BioFreedom stent

Biosensors International Group has announced both the Japanese Pharmaceuticals and Medical Devic...

First patient enrolled in EXPAND TAVR II trial

Medtronic has announced the first patient enrolment in the EXPAND TAVR II pivotal trial, the fir...

SCAI issues position paper on transaxillary arterial access

The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...

Translumina announces launch of dual drug polymer-free coated stent

Translumina has announced the launch of Vivo Isar, its latest generation dual drug polymer-free coat...

“Hybrid” model likely to be a hallmark of the post-pandemic era for heart failure care

The pandemic saw a boom in the use of remote technologies and telehealth for patient monitoring ...

FDA approves coronary use of XO Cross support catheter system

Transit Scientific has announced US Food and Drug Administration (FDA) clearance of its XO Cross...

Quest International and CathWorks partner to scale up FFRangio

Quest International and CathWorks have announced a strategic partnership. Quest has been selecte...

VenusP-Valve gains CE mark

VenusP-Valve
Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—VenusP-Valve—has received...

CeloNova to seek medical device partnerships

CeloNova BioSciences has announced the strategic decision to focus its core business on creating...

ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT

Patients treated with edoxaban for six months after a transcatheter aortic valve implantation (T...

Cardiovascular News’ top 10 most popular stories of March 2022

The most read stories from across Cardiovascular News in March 2022 include a wealth of late-breakin...

FEops Heartguide receives FDA clearance for LAAO planning capabilities

FEops has announced that it received authorisation from the US Food and Drug Administration (FDA...

First patient in Japan treated with Impella 5.5 with SmartAssist

Abiomed has announced that the first patient in Japan has been treated successfully with Impella...

First patient enrolled in BIOMICS study for CTO-PCI

Biosensors International has announced the enrolment of the first patient in the BIOMICS study, a pr...

ACC.22: Analysis finds lower rate of structural valve deterioration with TAVI than SAVR at five years

Patients who received a transcatheter supra-annular self-expanding heart valve had less structural d...

ACC.22: NACMI registry finds reducing rates of death among STEMI patients with COVID-19

Latest results from the North American COVID-19 STEMI (NACMI) registry reported a 25% reduction ...

ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis

A head-to-head comparison of fractional flow reserve (FFR) and intravascular ultrasound (IVUS) guide...

ACC.22: Three-year data show “durable blood pressure reductions” through renal denervation

Long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial have been presented during ...

ACC.22: “Promising” one-year results for Pascal device in CLASP-TR trial

Patients with tricuspid regurgitation (TR) who received a Pascal transcatheter valve (Edwards Lifesc...

Corvia announces publication of REDUCE LAP-HF II data

Corvia Medical has announced publication of analyses from its global, phase III REDUCE LAP-HF II...

ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery

Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) leads to a fast...

SafeCross transseptal balloon gets first commercial use

East End Medical has announced the first commercial use of its SafeCross transseptal radiofreque...

Philips launches Ultrasound Workspace at ACC.22

Royal Philips is launching an echocardiography image analysis and reporting solution—Ultrasound Work...

SCAI aims to minimise risks in medical proctoring of new techniques and technologies

The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...

FDA approval granted for Mitris Resilia mitral valve replacement

Edwards Lifesciences has announced it received approval from the US Food and Drug Administration (FD...

Shockwave coronary IVL gains Japanese approval

Shockwave Medical’s C2 coronary intravascular lithotripsy (IVL) catheter has received regulatory app...

First patient enrolled in PICSO-AMI-V study

Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V study to evaluate Pi...

RADIANCE-II renal denervation trial completes enrolment

Investigators have completed enrolment in the RADIANCE-II pivotal trial of the Paradise ultrasound r...

Carmat sets date for resumption of implants of artificial heart system

Carmat, designer and developer of an advanced total artificial heart, has issued an update on it...

Deep learning tool could predict future myocardial infarction

Researchers have detailed the use of an artificial intelligence-enabled tool for atherosclerotic...

First-in-human study paves way for further clinical trials of Valvosoft

Cardiawave has announced the success of its first-in-human I (FIH I) safety and feasibility clinical...

Expert group sets out principles for device-led hypertension trials

A consensus document outlining design principles and outcome definitions for device-based therapies ...

Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system

Four radial cases using the PH Band System (Medical Ingenuities)—a novel medical device that is ...

Venus Medtech targets European growth with senior appointment

Venus Medtech has appointed Shakeel Osman as senior vice president of sales Europe, responsible for ...

Women less likely to receive cardiogenic shock treatment

Woman patient
Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to r...

Dyspnoea and fatigue “warning signs of greater risk” for NSTEMI patients

Only 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one ye...

Putting “stent regret” behind us

Nick West, chief medical officer and divisional vice president of Global Medical Affairs, Abbott...

Xeltis announces “promising outcomes” in restorative graft trials following EU financing

Xeltis has announced promising initial outcomes from two key vascular trials involving its restorati...

ACC issues clinical guidance on cardiovascular consequences of COVID-19

The American College of Cardiology (ACC) has issued an expert consensus decision pathway for the eva...

CSI’s Propel pVAD system gets first-in-human use

Cardiovascular Systems—CSI—has announced the first in-human experience with Propel, its first-genera...

First patient treated in study of PerQseal+ vessel closure device

Vivasure Medical has announced today that the first patient was treated in a US early feasibilit...

Cardiologists without borders

“When I was one year old, my father died in the war between Israel and Egypt and I was left with...

Ryan Egeland joins Big Sky Biomedical

Big Sky Biomedical has appointed Ryan Egeland as managing director. “Big Sky Biomedical was f...

Medtronic expands reach of AI-powered surgical video management and analytics platform

Medtronic has announced that it has entered into a contract with Vizient to add Touch Surgery En...

Cardiovascular News’ top 10 most popular stories of February 2022

The most read stories from across Cardiovascular News in February 2022 include training for robotic ...

CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI

Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical outcomes after transcat...

CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition

A novel transcatheter system designed for transfemoral mitral valve repair—the NeoChord Nexus sy...

CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT

Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual antiplatelet therapy...

CRT 2022: Four-year LRT data “support TAVI in low-risk patients”

Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aortic valve implantatio...

VISION study concludes troponin is a benchmark for cardiac surgery risk

Levels of high-sensitivity troponin I after cardiac surgery that were associated with an increased r...

Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed

Biotronik has announced final enrolment in the BIOMAG-I clinical trial by Michael Haude (Rheinla...

CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX

Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientif...

Women underrepresented in cardiovascular clinical trial leadership positions

Women remain underrepresented in leading cardiovascular clinical trials, corresponding with unde...

CRT 2022 hears results of animal study of Tria TAVI valve

Tria
Results from the first animal study of the Tria transcatheter aortic valve (Foldax) have been pr...

CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years

Final five-year results from the BIOFLOW-V trial, presented during a late-breaking trial session...

Partnership to promote wearable tech in cardiology trials

Wearable technology and digital health specialist Activinsights has announced a partnership agreemen...

High coronary artery calcium score increases risk of heart attack or stroke

Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a mor...

CX 2022 returns to in-person format facing challenges and opportunities in the aortic field

Anticipation is building for the Charing Cross International Symposium 2022 (CX 2022). This will...

Teleflex catheters and coronary guidewires cleared for CTO PCI

Teleflex has announced that the US Food and Drug Administration (FDA) has cleared an expanded indica...

New data underpin drive towards earlier AF ablation strategies

Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have...

Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality

Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated with lower in-hospi...

Siemens introduces “integrated” cath lab imaging system, Artis icono biplane

Siemens Healthineers has announced the launch of Artis icono biplane—an angiography system with dete...

Ross procedure “associated with better long-term outcomes” for aortic valve replacement

The “Ross procedure” may be a more favourable option for aortic valve replacement among patients...

Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure

Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indicat...

On-pump and off-pump CABG confer similar outcomes over 10 years

A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary artery bypass graftin...

Heart team approach points to mortality benefit in complex cardiac patients

Consultation by a heart team led to an observed benefit in objective patient outcomes, a prospective...

New technique outperforms manual assessment of thoracic aortic aneurysm growth

Researchers have developed a novel method of measuring growth of thoracic aortic aneurysm, which the...

Robert Califf to return as US FDA commissioner

Cardiologist and researcher Robert Califf has been confirmed as the commissioner of the US Food ...

Expanded robotic training will benefit cardiovascular care

Robotic systems have the potential to fundamentally change the way care is delivered to patients in ...

3D printing to support physician training and coronary device testing

The donation of new 3D printing technology to the Visible Heart Laboratories at the University o...

Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant

Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled tri...

Boston Scientific closes acquisition of Baylis Medical Company

Boston Scientific has announced the close of its acquisition of Baylis Medical Company, a compan...

MedHub announces investment and pivotal study completion

MedHub has announced the completion of a funding round worth US$1 million in new financing, alongsid...

Supreme drug-eluting stent “safe and effective” in complex coronary lesions

The Supreme healing-targeted drug-eluting stent (Sinomed) is effective and safe at one year acro...

Portsmouth Hospital: How tech is guiding decision-making in the cath lab

Peter Haworth (Portsmouth Hospitals University NHS Trust, Portsmouth, UK) documents how computer-der...

HeartFlow and Longview terminate merger agreement

HeartFlow has announced that it and Longview Acquisition Corporation have mutually agreed to termina...

Lung cancer patients with higher level of coronary calcium at increased risk for adverse cardiovascular events

Lung cancer patients with higher amounts of coronary artery calcium have an increased risk of an adv...

IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation

The use of intravascular ultrasound (IVUS) guidance for implantation of drug-eluting stents in long ...

Cardiovascular News’ top 10 most popular stories of January 2022

cardiovascular news top 10
The most read stories from across Cardiovascular News in January 2022 include controversy surroundin...

Acarix submits breakthrough designation request to FDA for heart failure diagnosis tool

Acarix has submitted a breakthrough designation request for its technology for heart failure diagnos...

“Game changing” photon-counting CT system arrives at John Radcliffe Hospital

The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundation Trust (OUH, Oxfor...

Philips expands haemodynamic assessment in its Lumify handheld ultrasound system

Royal Philips has announced an update to its handheld ultrasound platform—Lumify—adding Pulse Wave D...

Second phase of ASCENT ASD trial begins

Atheart Medical has announced that it has received US Food and Drug Administration (FDA) approva...

Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial

The placement of an interarterial shunt device—the Corvia atrial shunt (Corvia Medical)—did not ...

First patient enrolled in RISE SC study of coronary balloon

Biosensors has announced the enrolment of the first patient in the RISE SC study, a single arm, pros...

Breakthrough designation granted to CardiaAMP cell therapy system for heart failure treatment

BioCardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Devi...

CroíValve completes funding round for study of Duo system

CroíValve has raised a Series A round to fund a feasibility clinical study with its Duo Coaptati...

SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation

The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the release ...

Abbott’s Nick West points to future role of AI in the cath lab

Abbott has released a second round of insights from its Beyond Intervention global research prog...

ADVERTORIAL: Fresh data paint a positive picture for IVL in both eccentric and nodular coronary calcium

This advertorial is sponsored by Shockwave Medical. The latest data from the Disrupt CAD clinical...

ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases

This advertorial is sponsored by Medtronic. Evolut PRO+ is the latest generation of self-expandin...

Susheel Kodali

Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in New York, where he ...

Cardiovascular News 64 – February 2022: US Edition

In this issue:  Coronary revascularisation guidelines spark debate New data on IVL in eccent...

Cardiovascular News 64 – February 2022: OUS Edition

In this issue:  Coronary revascularisation guidelines spark debate New data on IVL in eccent...

STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery

Insights from what was described as the “largest and most comprehensive” analysis of isolated su...

PROACT clinical trial results published for On-X mechanical mitral valve

Artivion has announced the publication of PROACT clinical trial results in The Annals of Thoracic Su...

SCAI issues updated expert consensus statement on cardiogenic shock

The Society for Cardiovascular Angiography and Interventions (SCAI) has released its updated exp...

STS 2022: Closer ties between surgeons and cardiologists among goals for incoming president

Cardiothoracic surgeon John H Calhoon from The University of Texas Health Science Center (UT Hea...